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Article history:

The aggregation of the 37-amino acid polypeptide islet amyloid polypeptide (IAPP, amylin),

Received 5 September 2014

as either insoluble amyloid or as small oligomers, appears to play a direct role in the death
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of pancreatic β-islet cells in type 2 diabetes. It is believed that inhibiting the aggregation of
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IAPP may slow down, if not prevent entirely, the progression of this disease. Extracts of 13
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different common fruits were analyzed for their ability to prevent the aggregation of
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amyloidogenic IAPP. Thioflavin T binding, immuno-detection and circular dichroism assays
were performed to test the in vitro inhibitory potential of each extract. Atomic force mi-

Keywords:

croscopy was used to visualize the formation of amyloid fibrils with and without each fruit

Amyloid inhibition

extract. Finally, extracts were tested for their ability to protect living mammalian cells from

Diabetes

the toxic effects of amyloid IAPP. Several fruits showed substantial ability to inhibit IAPP

Natural product therapeutics

aggregation and protect living cells from toxic IAPP amyloid.

1.

Introduction

The natural products isolated from fruit extracts have been associated with many positive health benefits. These health
benefits span a variety of fields, showing beneficial
functionalities for anti-cancer (Chia-Hung, Chi-Chou, Hsu, Kao,
& Wang, 2015; Olsson, Gustavsson, Andersson, Nilsson, & Duan,
2004; Zunino, Zhang, Seeram, & Storms, 2010), anti-aging
(Shukitt-Hale, Carey, Jenkins, Rabin, & Joseph, 2007), and antiobesity (Chaudhary et al., 2014) to name a few. Previous studies
have indicated that several individual fruits are capable of inhibiting the formation of protein aggregates associated with
amyloid-linked diseases, such as Alzheimer’s disease and type

2 diabetes (Li, Jang, Sun, & Surh, 2004; Park, 2010; Zhu, Bickford,
Sanberg, Giunta, & Tan, 2008). However, to the best of our knowledge, no study has been performed to directly compare the
efficacy of multiple fruits, spanning several fruit families, at
inhibiting amyloid formation. In this work, 13 common fruits
were analyzed for their ability to prevent the aggregation of
amyloidogenic islet amyloid polypeptide (IAPP), the amyloid
protein associated with the progression of type 2 diabetes. The
natural propensity of IAPP to aggregate into toxic amyloidogenic
species is believed to occur in a similar fashion as other
amyloidogenic proteins, such as Aβ42 in Alzheimer’s disease
and α-synuclein in Parkinson’s disease. Fruit extracts capable
of inhibiting the aggregation of IAPP, considered one of the most
amyloidogenic protein known (Cao, Abedini, & Raleigh, 2013a),
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are likely to function as inhibitors of other amyloid proteins
as well (Montane, Klimek-Abercrombie, Potter, Westwell-Roper,
& Verchere, 2012).
The incidence of type 2 diabetes within developed
nations continues to increase. The American Diabetes Association estimates that 25.8 million Americans have diabetes
(approximately 8.3% of the population (″Type 2 Diabetes Facts
and Figs″, 2011)), with nearly 2 million new cases diagnosed
each year. While obesity is a factor in the development of type
2 diabetes, over 70% of obese people do not have diabetes, suggesting that other factors influence the progression of this
disease (CDC-National Center for Health Statistics, National Data
Brief, No. 82, Jan 2012) (Ogden, Carroll, Kit, & Flegal, 2014a, 2014b).
One possible factor linked to the progression of type 2 diabetes is the aggregation of the amyloidogenic peptide islet
amyloid polypeptide (IAPP) (Montane et al., 2012). This 37amino acid polypeptide is co-secreted from pancreatic β-islet
cells with insulin. During the progression of type 2 diabetes,
IAPP aggregates into a variety of different amyloidogenic states
(Abedini & Schmidt, 2013; Apostolidou, Jayasinghe, & Langen,
2008; Hull, Westermark, Westermark, & Kahn, 2004; Kahn,
Andrikopoulos, & Verchere, 1999). While the exact structure and
nature of these aggregates remains to be determined, it is clear
that some of these aggregates are highly toxic to cells (Andrews,
Inayathullah, Jayakumar, & Malar, 2009; Cao et al., 2013b; Nanga,
Brender, Xu, Veglia, & Ramamoorthy, 2008). For example,
Eisenberg and coworkers recently suggested that the most toxic
form of IAPP may self-assemble into a cylindrin structure
(Laganowsky et al., 2012; Liu et al., 2012). These oligomeric structures seem to be the toxic form of the amyloid proteins. While
the exact mechanism of toxicity remains unknown, two theories suggest that the oligomers either (1) form pores in the
cellular membranes or (2) disrupt cellular membranes through
membrane fragmentation (Brender, Salamekh, & Ramamoorthy,
2012). Ramamoorthy and coworkers have used NMR to solve
the structures of several human and rat IAPP peptides under
a variety of conditions, including within micelles (Brender, Durr,
Heyl, Budarapu, & Ramamoorthy, 2007; Brender et al., 2008;
Nanga et al., 2008, 2009; Soong, Brender, Macdonald, &
Ramamoorthy, 2009). Regardless of the exact structure of the
IAPP aggregates, their toxicity to cells may be the root cause
of the progression of type 2 diabetes (Ritzel, Meier, Lin, Veldhuis,
& Butler, 2007). Likewise, the toxicity of these aggregates appears
to preclude the use of β-cell transplantation therapies (Potter
et al., 2010). The possibility exists that preventing the formation of toxic IAPP aggregates could slow, if not prevent entirely,
the progression of type 2 diabetes. Additionally, inhibiting the
formation of these toxic aggregates may make future pancreatic β-cell transplantation therapies a reality.
The fruits described in this study were chosen for analysis because of their abundant availability within the United
States and their distribution across several different fruit families. Because of the considerable levels of carbohydrates within
these fruits (a fact that prevents many diabetic patients from
ingesting large amounts of these fruits on a regular basis), we
chose an extraction method that removed over 99% of the carbohydrates from the samples. The resulting fruit extracts were
tested for their in vitro ability to prevent the formation of
amyloid aggregates and their ex vivo ability to protect living
mammalian cells from toxic IAPP amyloid.

2.

Materials and methods

2.1.

Preparation of fruit extracts

451

For each individual whole fruit, 100 g was ground using a mortar
and pestle in the presence of 100 mL of ethyl acetate. The resulting slurry was filtered and the ethyl acetate layer isolated.
The ethyl acetate was removed via speed vacuum yielding approximately 8 aliquots of dehydrated solid extracts. These
dehydrated extracts were stored at −20 °C. Extracts were rehydrated by resuspending each aliquot in 150 µL 20 mM Tris
buffer pH 7.40 (standard solution) or 1.50 mL of the same buffer
(yielding samples 10× diluted).

2.2.

Preparation of IAPP stock solutions

IAPP stock solutions were prepared by dissolving 1 mg of synthetic amylin (Anaspec Corp. Fremont, CA, USA) in 8 mL of
hexafluorisopropanol (HFIP, Sigma Aldrich, St. Louis, MO, USA).
To fully disaggregate the IAPP, the sample was placed in a sonicating water bath for 5 min. This stock solution was stored at
−80oC for up to 2 months.

2.3.

Thioflavin T binding (ThT) assays

HFIP was removed from the IAPP stock solution under speedvacuum. The dry IAPP sample was resuspended in 20 mM Tris
buffer pH 7.40 containing each individual fruit extract. The final
in-solution concentration of IAPP was 106 µM. Aggregation was
initiated by incubating samples at 37 °C with shaking (200 rpm).
At designated time points, a 17 µL aliquot of each sample was
removed and mixed with 663 µL of 50.0 µM thioflavin T in 20 mM
Tris buffer pH 7.40. The IAPP/thioflavin T mixture was incubated at room temperature in the dark for 2 min before
recording the thioflavin T fluorescence emission spectrum
(Ex450nm) using a Hitatchi F-7000 fluorescence spectrophotometer.

2.4.

Atomic force microscopy (AFM)

Synthetic IAPP was prepared as described above and incubated with shaking in the presence of individual fruit extracts.
After 40 min of incubation, 20 µL of each sample were deposited onto freshly cleaved mica. After incubation at room
temperature for 5 min, the mica was washed with 200 µL sterilefiltered water and allowed to air dry. The samples were scanned
using an MFP-3D atomic force microscope (Asylum Research,
Santa Barbara, CA, USA) set on A/C mode and a 240 µm silicon
cantilever (Olympus Corporation of the Americas, PA, USA).
Images shown are the raw data with no flattening.

2.5.

Circular dichroism (CD)

CD spectroscopy was performed using a J-815 CD Spectrometer (Jasco Inc, Easton, MD, USA) with quartz cuvettes of 1 mm
pathlength. Samples were scanned from 190 to 250 nm. In order
to reduce interference by the fruit extracts, 10× diluted fruit
samples were mixed with IAPP. The final in-solution IAPP concentration was 76.8 µM. IAPP, in the presence and absence of
each fruit sample, was incubated for 40 min at 37 °C with
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2.6.

Immunoblot dot test

Samples of IAPP were incubated with individual fruit extracts as described in the thioflavin T assay above. At designated
time intervals, 2 uL of each IAPP sample (with or without a fruit
extract) were placed on a nitrocellulose membrane. The resulting membrane was allowed to air dry before blocking in
2.5% BSA in TBST buffer for 1 h at room temperature. After
blocking, the membrane was cut in half, with one half probed
with Millipore’s A11 antibody (AB9234) and the other half probed
with Millipore’s Fibril OC antibody (AB2286) (Millipore, Billerica, MA, USA). Both antibodies were applied at a 1:1000 (v,v)
dilution for 1 h at room temperature. The membranes were
washed three times for 5 min each with TBST buffer. The membranes were probed with donkey anti-rabbit secondary antibody
conjugated to HRP (1:2000 v,v) for 1 h at room temperature. The
membranes were washed three times with TBST buffer. A final
wash with TBS for 5 min was conducted before developing using
GE’s Amersham ECL reagent with a 10 min exposure time.
Images were taken using the Bio-Rad Imaging System.

2.7.

HeLa cell rescue

HeLa cells were incubated with 15 µM of synthetic IAPP prepared as described above. Equal amounts of HeLa cells were
plated in triplicate and incubated overnight in 96-well plates.
After 24 h, F-12K media with phenol red was replaced by DMEM/
F12 (1:1 v,v) without phenol red. Hexafluoroisopropanol (HFIP)
was evaporated from IAPP using a centrivap concentrator
(LabOnco). IAPP was re-suspended in DMEM/F12 media, the
pellets were then mixed into the media by vortexing (Vortex
Genie Mixer) for 2 min. Stock solutions of each fruit extract were
diluted with 25 mM Tris buffer (pH 7.4) and added to the appropriate wells. The treated cells were incubated for 22 h at
37 °C. Post-incubation, MTT (3-(4,5-dimethyl-2-thiazolyl)-2,5diphenyl-tetrazolium bromide) was added into each well and
incubated at 37 °C for 2 h. Formazan crystals, formed on the
bottom of the wells, were re-suspended in a solubilization buffer
(20% SDS and 50% dimethylformamide). The absorbance in each
well was taken at 570 nm using a BioRad 550 microplate reader.
HeLa cells and media were obtained from ATCC. All incubations took place in a water jacketed incubator in 5% carbon
dioxide at 37 °C (Shell Lab). The average percentage of cell viability was calculated for each of the conditions.

3.

Results

The ethyl-acetate extracts of several common fruits were analyzed to identify those having the greatest potential for
inhibiting the aggregation of amyloidogenic IAPP. Each
fruit extract was initially analyzed for its ability to prevent
thioflavin-T (ThT) binding to IAPP (Fig. 1). ThT binding is a facile
method for detecting and quantifying amyloid formation. ThT
shows little fluorescence emission when solubilized in an
aqueous solution. However, ThT fluorescence increases in a
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shaking (200 rpm). These rigorous conditions reproducibly
yielded IAPP fibrils (visible with Atomic Force Microscopy) with
CD spectra having a single minimum at 218 nm.
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Fig. 1 – Thioflavin T fluorescence of IAPP alone and IAPP in
the presence of each fruit extract. Fluorescence was
measured with an excitation wavelength of 450 nm and an
emission wavelength of 488 nm. The solution
concentration of IAPP was 106 µM for each sample. Data
are the average of at least three data sets.

concentration-dependent manner when in the presence of
amyloid (LeVine, 1993).
IAPP is believed to form a variety of different amyloidogenic
aggregates with varying degrees of cellular toxicity (Andrews
et al., 2009; Gazit, 2005; Haataja, Gurlo, Huang, & Butler, 2008).
IAPP with and without each fruit extract was probed with the
A11 antibody and the Fibril OC antibody (Fig. 2). The A11 antibody is an anti-oligomer antibody that specifically binds to
small soluble oligomers, believed to be the more toxic form of
IAPP amyloid. The Fibril OC antibody is an anti-fibril antibody
that specifically binds to the fibrillar form of IAPP. Dark spots
on the immuno-detection assays indicated the presence of the
amyloidogenic species, while colorless spots and white spots
both indicated the absence of amyloidogenic species.
A more direct method for assessing amyloid inhibition potential is through the visualization of amyloidogenic fibrils.
Atomic force microscopy (AFM) was used to visualize the formation of amyloid fibrils in the presence and absence of each
fruit extract (Figs 3 and 4). The use of AFM allows for a direct
detection of an amyloidogenic species in the presence and
absence of each fruit extract. Likewise, circular dichroism (CD)
spectroscopy was used to detect the conversion of unstructured IAPP peptides into the β-sheet-rich amyloidogenic species
of IAPP (Fig. 5). Finally, to test the ability of each fruit extract
to protect living cells from IAPP, the MTT assay was performed using HeLa cells (Fig. 6). The MTT levels of HeLa cells
alone were set as 100%. The addition of IAPP (labeled as amylin)
to the HeLa cells decreased the cell viability to 67% in less than
24 h. The 25 mm Tris buffer was tested to ensure that there was
no conflict with cell viability.

4.

Discussion

4.1.

Thioflavin T binding

The time course data for ThT binding to IAPP amyloid (Fig. 1)
indicated that most of the fruit samples were capable of slowing
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Fig. 2 – Immunoblot dot test. Samples containing IAPP alone or IAPP with each fruit extract were incubated at 37oC with
shaking (200 rpm). Two microliters of each sample was dotted onto nitrocellulose membrane and probed with A11 antibody
(top panels) or Fibril OC antibody (bottom panels). Dark spots indicate where the amyloid-binding antibodies detected
amyloid deposits. Blank and light spots indicate where amyloid was not present.

and/or preventing the aggregation of IAPP under rigorous
aggregate-forming conditions. The fruits showing the least inhibitory potential according to the ThT results were banana,
pineapple, and lemon. The remaining fruit extracts showed significant inhibitory potential. ThT binding by amyloid is a useful
diagnostic for gauging the ability of a potential therapeutic to
prevent amyloid formation. However, it is possible that the lack
of ThT fluorescence may be due to inhibition of ThT binding
to the amyloid, rather than preventing amyloid formation (this
has been experimentally observed in the case of EGCG competing with ThT for binding to IAPP) (Suzuki, Brender, Hartman,
Ramamoorthy, & Marsh, 2012). For this reason, it is important to conduct additional experiments to identify true amyloid
inhibitors and potential therapeutic agents.

4.2.

Immuno-detection

We chose to perform immuno-detection assays to identify
the amyloid species being inhibited by each fruit extract.
The results (Fig. 2) indicated that several fruits (banana,
tomato, mango and nectarine) had little inhibitory potential,
while the remaining fruits displayed some ability to prevent
IAPP amyloid formation. These results also suggest that both
IAPP oligomers and fibrils were inhibited in the presence of
most of the fruit extracts. The fruit extracts showing the
greatest inhibitory potential from these immuno-detection
assays were grape, strawberry, pomegranate and raspberry (all
of which were strong inhibitors according to the ThT results
in Fig. 1).

Fig. 3 – Atomic force microsope images of fruits showing modest to negligible ability to inhibit IAPP fibril formation. (a)
IAPP alone, (b) banana, (c) kiwi, (d) lemon, (e) mango, (f) nectarine, (g) strawberry and (h) tomato.
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Fig. 4 – Atomic force microsope images of fruits showing significant ability to inhibit IAPP fibril formation. (a) IAPP alone, (b)
blackberry, (c) blueberry, (d) grape, (e) pineapple, (f) pomegranate and (g) raspberry.

4.3.

Atomic force microscopy

AFM, a direct test that allows the visualization of amyloidogenic
fibrils, provided evidence suggesting that some fruit extracts
were stronger inhibitors than others. Due to the fact that significant amounts of fibrils were observed, several fruit extracts
(banana, kiwi, lemon, mango, nectarine, strawberry, and tomato)
showed little ability to inhibit IAPP fibril formation (Fig. 3). IAPP
fibrils were found on every AFM sample in the presence of these
non-inhibiting fruits. The remaining fruit extracts (blackberry, blueberry, grape, pineapple, pomegranate, and raspberry)
showed significant ability to inhibit fibril formation (Fig. 4) compared with IAPP in the absence of inhibitors. In every sample
tested, high concentrations of the fruit extracts prevented fibril
formation (Fig. 4). The strongest inhibitors of fibril formation
were the pomegranate, raspberry and blueberry extracts. When
diluted 100×, these three extracts still prevented fibril formation in all samples tested, whereas extracts of the other inhibitor
fruits (blackberry, grape and pineapple) began to lose potency
after a 10× dilution of the extract (minor amounts of fibrils could
be seen – data not shown).

4.4.

Circular dichroism

Like most amyloidogenic proteins, it is believed that the conversion of IAPP to an amyloidogenic state involves the formation
of β-sheet secondary structure. It is well documented that the
fibrillar form of IAPP forms a cross β-structure perpendicular
to the axis of the fibril. This conversion from unstructured
peptide to β-sheet was monitored via circular dichroism spectroscopy (CD). As IAPP adopts the β-sheet structure indicative
of amyloidogenic aggregates, the CD signal displays a local

minima at 218 nm. Fruit extracts found to prevent the conversion of IAPP into β-sheet rich structures are shown in Fig. 5A.
The CD signal of IAPP after incubation in the presence of inhibitory extracts (blackberry, blueberry, lemon, mango, nectarine,
raspberry and tomato) resembles the CD signal of IAPP prior
to incubation (data not shown). The fruit extracts of banana
and strawberry (Fig. 5B) showed little ability to prevent the conversion to β-sheet rich structures. Several fruit extracts
(pomegranate, pineapple, grape, and kiwi) possessed CDactive extracts that interfered with the IAPP signal.

4.5.

Cell rescue

To test the potential of fruit extracts to protect living cells from
toxic IAPP aggregates, the MTT assay was performed using HeLa
cells (Fig. 6). The MTT assay, which quantitates the oxidative
capacity of HeLa cells after treatment with the respective fruit
extract and/or IAPP, indicated that certain fruit extracts had
greater protective qualities compared with others. The addition of nectarine, raspberry, and pineapple significantly rescued
the HeLa cells (p < 0.05, t-test) from the toxic effects of IAPP.
Tomato and banana extracts demonstrated the least potential for rescuing cells from IAPP toxicity. Several fruit extracts
(strawberry, blackberry, lemon and kiwi) seemed to hinder cellular viability even in the absence of IAPP.

5.

Conclusions

This comparative study evaluated the ability of common fruit
extracts to inhibit the aggregation of IAPP into toxic amyloid

journal of functional foods 12 (2015) 450–457
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Fig. 5 – Circular dichroism of IAPP after 40 min incubation. (a) Fruits showing significant ability to prevent the conversion of
IAPP to β-sheet conformation, (b) fruits showing negligible ability to prevent the conversion of IAPP to β-sheet conformation
and (c) fruits with UV-active extracts that interfered with monitoring of the IAPP β-sheet transition.
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Fig. 6 – Relative cell viability (%) in the presence of IAPP and/or fruit extracts. The “Media” and “Buffer” samples represent
cell viability in the presence of media alone and media with Tris Buffer respectively (no IAPP was included in these
samples). “Amylin” shows the effect of IAPP on cell viability. Gray bars indicate samples with IAPP and the specified fruit
extract. White bars correspond to the effect of each individual fruit extract alone (with no IAPP present) on the viability of
cells.
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species. These results indicate that many fruits possess the
potential to inhibit IAPP aggregation, but several fruits were
found to have significantly greater inhibitory activity. The fruit
extracts with the greatest overall ability to prevent amyloid aggregation and simultaneously protect living cells from IAPP
toxicity were the berries, raspberry and blueberry. Also showing
substantial inhibitory activity were the pomegranate and
grape extracts. Conversely, the banana and kiwi extracts
showed virtually no inhibitory activity. The remaining
fruits tested possessed moderate activity, showing mixed
levels of aggregation inhibition in the various experiments
performed.
The use of ethyl acetate as the extraction solvent yielded
two beneficial outcomes. First, over 99% of the total carbohydrate of each extract remained within the aqueous phase (data
not shown). Therefore, this choice of extraction solvent removed
over 99% of the total sugar content. Because individuals suffering from type 2 diabetes must control their sugar intake, this
extraction process could be used to produce a therapeutically viable form of each fruit. Second, the use of ethyl acetate
pulls out and concentrates polyhydroxylated phenols and catechins, classes of compounds believed to possess a range of
positive health benefits, including inhibition of amyloid
formation.
From these results, we believe it is unlikely that the inhibitory component(s) for each fruit extract are the same. In our
studies, the extracts from raspberry, blueberry and blackberry all performed well and were considered strong inhibitors
of amyloid formation. Both raspberry and blackberry contain
a substantial amount of flavanols such as EGCG, a known inhibitor of IAPP aggregation (Cao & Raleigh, 2012; Tang, 2007).
Conversely, blueberry contains very little EGCG and flavanol
content, yet was found to be an equally good inhibitor compared with raspberry and blackberry. Likewise, the amyloid
inhibitory potential of each fruit extract was not necessarily
linked to the anti-oxidant content of each fruit. Grapes, one
of the strongest inhibitors of IAPP aggregation, have roughly
the same antioxidant content as nectarines, bananas, and kiwis,
the worst performers in this study.
The folding (or misfolding) process proteins undergo in their
transition into toxic amyloid is not yet fully understood.
However, it is believed that despite their differences in amino
acid sequences and compositions, the majority of amyloid proteins undergo a similar aggregation pathway that leads to
structurally similar amyloidogenic aggregates. Because of this,
it is possible that substances capable of inhibiting the aggregation of one amyloid protein may also be capable of inhibiting
others. Because IAPP is considered to be one of the most
amyloidogenic proteins known, substances found to inhibit this
amyloid protein may be potential therapeutics for other amyloid
proteins, such as Aβ42 aggregation in Alzheimer’s disease or
α-synuclein in Parkinson’s disease (Fox et al., 2010).
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